SARMs have been quite in news for a couple of years for their preference over typical steroids and prohormones which do more bad than good. However, there is a new related compound in town which is believed to be even better.
The New Sensation
The newest addition in various types of selective androgen receptor modulator is LGD-3303 which itself is a drug that acts as a SARM but has better selectivity and an exemplary oral bioavailability which allows the maximum utilization of SARM with simple oral intake. It is categorized as a selective androgen receptor agonist and works as both an anabolic and androgenic.
Currently, this SARM is undergoing preclinical trials to study the additive effect of the drug with bisphosphonate to treat osteoporosis.
A Sneak Peek Into The Past
The credit for the discovery of this SARM goes to Lingad Pharmaceuticals which started the work on the basis of coming up with an oral supplement that can influence the growth of bones and muscles. Chemically the drug resembles another class of SARMs that is lgd3033 but is still not available in the market as contrary to the latter.
What Does This New SARM Actually Do?
Even though SARMs works similar to anabolic steroids, the reason they are preferred is because of their selective action and same applies to this new SARM. Instead of initiating an androgenic effect in all the cells that exist in the human body and leading to claustrophobic effects, this latest SARM work by commencing the androgenic effect in only the targeted muscle tissues and cells. This is how this non-steroidal SARM works to increase muscle mass thereby facilitating in bodybuilding and helps people with low bone density by increasing both bone mineral density and bone mineral content according the preclinical trials.